Evidence map›Paper›PMID 24690941›Full record

Trial reportJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2014

MRI before intraarterial therapy in ischemic stroke: feasibility, impact, and safety.

Claus Z Simonsen, Leif H Sørensen, Sanja Karabegovic, Irene K Mikkelsen, Marie L Schmitz, Niels Juul, Albert J Yoo, Grethe Andersen

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Imaging biomarkers in acute ischemic stroke trials: a systematic review.AJNR. American journal of neuroradiology · 2015
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Claus Z SimonsenDepartment of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Leif H SørensenDepartment of Neuroradiology, Aarhus University Hospital, Aarhus, Denmark.
Sanja KarabegovicDepartment of Neuroradiology, Aarhus University Hospital, Aarhus, Denmark.
Irene K MikkelsenCenter for Functionally Integrative Neuroscience, Aarhus University, Aarhus, Denmark.
Marie L SchmitzDepartment of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Niels JuulDepartment of Neuroanaestesiology, Aarhus University Hospital, Aarhus, Denmark.
Albert J YooDivision of Diagnostic and Interventional Neuroradiology, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Grethe AndersenDepartment of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Aarhus University Hospital · DKAarhus University · DKHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intraarterial therapy (IAT) in acute ischemic stroke is effective for opening occlusions of major extracranial or intracranial vessels. Clinical efficacy data are lacking pointing to a need for proper patient selection. We examined feasibility, clinical impact, and safety profile of magnetic resonance imaging (MRI) for patient selection before IAT. In this single-center study, we collected epidemiologic, imaging, and outcome data on all intraarterial-treated patients presenting with anterior circulation occlusions at our center from 2004 to 2011. Magnetic resonance imaging was the first imaging choice. Computer tomography (CT) was performed in the presence of a contraindication. We treated 138 patients. Mean age was 64 years and median National Institutes of Health Stroke Scale (NIHSS) was 17. Major reperfusion (thrombolysis in cerebral infarction (TICI) 2b+3) was achieved in 52% and good outcome defined as modified Rankin Scale (mRS) score 0 to 2 at 90 days was achieved in 41%. Mortality at 90 days was 10%. There was only one symptomatic hemorrhage. Recanalization, age, and stroke severity were associated with outcome. Preprocedure MRI was obtained in 83%. Good outcome was significantly associated with smaller diffusion-weighted imaging (DWI) lesion size at presentation and not with the size of the perfusion lesion. It is feasible to triage patients for IAT using MRI with acceptable rates of poor outcome and symptomatic hemorrhage.

Indexed as

Cerebral AngiographyMagnetic Resonance AngiographyAgedBrain IschemiaHumansMiddle AgedProspective StudiesStrokeTomography, X-Ray Computed

Identifiers

PMID24690941
PMCPMC4050253
OpenAlexW2046916918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.